IFNW1抗体—艾普蒂

+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human esophagus cancer tissue using P09096(IFNW1 Antibody) at dilution 1/220. (Original magnification: ×200)    

  
  

IFNW1 (Interferon Omega-1) is a member of the type I interferon family, a group of cytokines critical in mediating innate immune responses against viral infections and modulating adaptive immunity. Unlike other type I interferons (e.g., IFN-α/β), IFNW1 is less characterized but shares structural homology and signaling pathways via the common IFN-α/β receptor (IFNAR). It activates JAK-STAT signaling, inducing interferon-stimulated genes (ISGs) with antiviral, immunoregulatory, and antiproliferative effects. IFNW1 is primarily studied in the context of antiviral defense, autoimmune disorders, and cancer immunotherapy due to its potential to enhance immune cell activity and suppress tumor growth.

Antibodies targeting IFNW1 are essential tools for elucidating its biological roles. These antibodies, often monoclonal or polyclonal, enable detection and quantification of IFNW1 in research settings, including ELISA, Western blot, and immunohistochemistry. They are also used to neutralize IFNW1 activity in functional studies to dissect its signaling mechanisms. Recent interest in IFNW1 antibodies has grown in therapeutic development, particularly for autoimmune diseases where excessive interferon signaling contributes to pathology. However, commercial availability remains limited compared to antibodies against other interferons, reflecting IFNW1's niche research focus. Further studies are needed to clarify its distinct functions and therapeutic potential relative to other type I interferons.